The Department of Neurosurgery is a master's and doctoral training site of Shandong First Medical University, the Clinical and Translational Ward for Brain-Computer Interface of Shandong First Medical University, the Clinical Base for Neuromodulation and Restoration of Shandong First Medical University, a Shandong Provincial Clinical Boutique Specialty, a National Top 100 Excellent Thrombectomy Department, one of the first batch of National Neurointervention Construction Centers, one of the first batch of National Neurosurgery Construction Centers, a Surgical Diagnosis and Treatment Base for Cerebral Hemorrhage, a National Advanced Stroke Center and a Shandong Provincial Demonstration Advanced Stroke Center, a Tai'an Municipal Key Discipline, a Tai'an Municipal Clinical Key Specialty, a Tai'an Municipal Medical Quality Demonstration Department, and a Tai'an Municipal Excellent Nursing Service Demonstration Ward. The department director is Professor Zhang Liangwen, a member of the team of Academician Lu Lin, President of Shandong First Medical University, and a renowned domestic neurosurgery expert. Professor Zheng Wei serves as Executive Deputy Director of the department, and Professors Xie Fangmin and Zhang Chunpu serve as Deputy Directors.
The department currently has two independent wards, 5 subspecialty groups, 82 open beds, 62 professional medical and nursing staff, and 25 specialty physicians. The high-end hybrid operating room can complete a variety of complex operations in a one-stop manner. The department has advanced medical equipment and examination and treatment means, including CT, MRI, DSA, Zeiss and Leica fluorescence surgical microscopes, STORZ neuroendoscopes, Cadwell neuroelectrophysiological monitoring equipment, Leksell stereotactic apparatus, Remebot neurosurgical robot, NSK neurosurgical power system, and transcranial Doppler ultrasound.
Following the concepts of first-class domestic neurosurgery centers and the development direction of “a hospital with distinctive features, departments with key focuses, and individuals with specialties,” the department is divided into 5 subspecialty groups: the Neuromodulation and Restoration Center, the Brain and Spinal Cord Tumor Functional Group, the Ischemic Cerebrovascular Disease Group, the Hemorrhagic Cerebrovascular Disease Group, and the Craniocerebral Trauma Group.
The Department of Neurosurgery currently has 1 doctoral supervisor and 6 master's supervisors, 11 chief physicians (professors), 8 associate chief physicians (associate professors), and 3 associate chief nurses (associate professors), including 6 holders of medical doctorates and 21 holders of master's degrees in medicine.
The department maintains close academic exchanges and clinical business interactions with many famous hospitals and neurosurgery centers at home and abroad (including Keck Hospital of USC in the United States, the Affiliated Hospital of the University of Sassari in Italy, Beijing Tiantan Hospital, Xuanwu Hospital, Sanbo Brain Hospital, Qilu Hospital, and Shandong Provincial Hospital). All key physicians have received further training at well-known medical institutions at home and abroad, understand international neurosurgery development trends and frontier theories, master modern neurosurgery concepts and diagnostic and treatment methods, and have rich clinical diagnosis and treatment experience.
Subspecialty Introductions
I. Clinical Base of the Neuromodulation and Restoration Center of Shandong First Medical University
Since its establishment, the base has carried out a series of neuromodulation surgeries, including the first motor cortex stimulation in Shandong Province for intractable thalamic pain, the first spinal cord stimulation for arousal promotion in a vegetative patient in Tai'an, and the first spinal cord stimulation for diabetic foot peripheral neuropathy in Tai'an. It has also established a national renowned expert studio for neuromodulation and restoration, inviting three renowned domestic neurosurgery experts—Professors Zhang Li, Meng Fangang, and Hu Yongsheng—as distinguished professors to take turns seeing patients and performing surgery at the hospital, greatly improving the department's medical level and influence.
The Clinical and Translational Ward for Brain-Computer Interface of the Second Affiliated Hospital of Shandong First Medical University was planned under the personal guidance of Academician Lu Lin. It integrates the advantageous resources of the hospital's Department of Neurosurgery, Department of Neurology, Department of Rehabilitation Medicine, Department of Clinical Psychology, and Department of Medical Imaging. The ward is located in Ward II of the Department of Neurosurgery. It fully leverages the university (hospital)'s advantages in science-education integration and collaborative innovation among teaching, research, and medicine, builds a clinical translation platform for brain-computer interface, promotes cross-boundary integration among research institutions, medical institutions, and enterprises, constructs a collaborative innovation community integrating “industry, academia, research, and application,” accelerates the clinical application and translation of brain-computer interface technology, promotes the implementation of cutting-edge medical technology in Shandong, and builds a leading brain-computer interface innovation highland integrating “basic research—clinical application—talent cultivation.”
The diagnosis and treatment features of the Neuromodulation and Restoration Center include: microvascular decompression and radiofrequency ablation for trigeminal neuralgia for cranial nerve diseases such as intractable trigeminal neuralgia, hemifacial spasm, and glossopharyngeal neuralgia; deep brain stimulation for movement disorders such as Parkinson's disease, Meige syndrome, and essential tremor; spinal cord stimulation for arousal promotion in vegetative patients and for treatment of neuropathic pain and post-stroke dystonia; and surgical treatment of psychiatric diseases (treatment-resistant depression, obsessive-compulsive disorder, schizophrenia, etc.). The surgical results are leading domestically, and the surgical volume ranks first in the region.
II. Brain and Spinal Cord Tumor Functional Group
The group carries out comprehensive treatment of various benign and malignant intracranial and spinal tumors, is committed to the precise, minimally invasive, and comprehensive treatment of various brain and spinal cord tumors, protects patients' neurological function with superb techniques, and formulates individualized treatment plans for each patient through multidisciplinary collaboration.
It routinely carries out neuronavigation, intraoperative electrophysiological monitoring, and fluorescence-guided microscopy/neuroendoscopic surgery. It is skilled in using minimally invasive approaches such as keyhole and transsphenoidal approaches to tackle tumors in complex areas such as the brainstem and skull base, maximizing tumor resection while protecting brain function.
Comprehensive treatment system: Relying on the hospital's multidisciplinary team (MDT) platform and cooperating with the Department of Oncology, Department of Radiotherapy, Department of Imaging, and Department of Pathology, it integrates surgery, radiotherapy, chemotherapy, targeted therapy, and immunotherapy for patients and provides scientific and coherent full-cycle management.
Critical care and rehabilitation support: A professional neurocritical care team and a modern NICU are available, and perioperative management is safe and rigorous. Early rehabilitation intervention is emphasized to promote the recovery of patients' neurological function and improvement of quality of life.
The diagnosis and treatment features of the Brain and Spinal Cord Tumor Functional Group include: microsurgery for various intracranial tumors (meningioma, glioma, acoustic neuroma, intracranial metastatic tumors, etc.) and intraspinal tumors (meningioma, schwannoma, and intramedullary tumors); neuroendoscopic transsphenoidal resection of pituitary tumors, craniopharyngiomas, and other tumors; surgical treatment of craniovertebral junction malformations; diagnosis and treatment of various types of hydrocephalus (including normal-pressure hydrocephalus); and clinical application of neurosurgical navigation robots (stereotactic puncture biopsy of intracranial lesions, puncture and drainage of brain abscesses, SEEG, etc.).
III. Ischemic Cerebrovascular Disease Group
The group is committed to opening blocked cerebral blood vessels, fighting for patients' chance of survival, and minimizing disability and mortality rates. Mechanical thrombectomy for acute cerebral infarction is at the national advanced level: the department has Grade A in AIS interventional recanalization of the National Stroke Construction Center, marking that our technical strength and treatment effects have reached the domestic first tier. The National Stroke Center awarded the department “National Top 100 Excellent Thrombectomy Department,” and it is the thrombectomy team with the most mature technology and richest experience in the region. The ischemic stroke team of the Department of Neurosurgery adheres to the concept that “time is brain, time is life.” The green channel is on standby 7 days × 24 hours. At the same time, through multidisciplinary collaboration, the Department of Neurosurgery, Department of Emergency, Department of Imaging, and Department of Anesthesiology are seamlessly connected to achieve “admission—imaging—surgery” one-click activation. This ensures that patients can receive the fastest and most effective interventional treatment at any time. Our ischemic stroke team is not only a technical highland of the hospital but also a strong backing for regional cerebrovascular disease emergency care. Our treatment network has fully covered the entire Tai'an area and surrounding areas such as the provincial capital. We provide strong technical support and convenient referral channels for primary hospitals, ensuring that critically ill stroke patients in surrounding areas can be transferred to our center as soon as possible and receive domestic top-level interventional thrombectomy treatment, truly achieving national-level treatment “at the doorstep.”
The combination of stroke and the domestically leading brain-computer interface enables patients to achieve integrated surgical and rehabilitation treatment, enhancing treatment effects.
Thrombolytic treatment for central retinal artery occlusion is one of the few “vision-restoring” treatment centers in China, restarting a “clear” life for patients with sudden blindness and earning a good social reputation.
The diagnosis and treatment features of the Ischemic Cerebrovascular Disease Group include: mechanical thrombectomy (National Top 100) and arterial thrombolysis for acute ischemic stroke; thrombectomy and thrombolysis for intracranial venous sinus thrombosis; individualized blood flow reconstruction for chronic occlusion of head and neck vessels (including hybrid surgery); carotid endarterectomy and minimally invasive stent placement for carotid artery stenosis; stent placement for intracranial vascular stenosis; recanalization of chronic intracranial vascular occlusion; intracranial-extracranial vascular bypass for moyamoya disease and occlusive vascular diseases; and interventional thrombolytic treatment for central retinal artery occlusion (sudden blindness).
IV. Hemorrhagic Cerebrovascular Disease Group
For many years, the group has been committed to carrying out diversified clinical and basic research on cerebrovascular diseases and has become a subspecialty group with advanced equipment and excellent technology, featuring minimally invasive treatment. It focuses on the clinical diagnosis, treatment, and research of hemorrhagic cerebrovascular diseases, takes minimally invasive treatment as the core development direction, integrates international advanced equipment such as fluorescence surgical microscopes, neuroendoscopes, and Remebot neurosurgical robots, and has built a precise diagnosis and treatment system covering the full cycle of “diagnosis—treatment—rehabilitation.” Relying on the National Stroke Center and the National Training Base for Cerebral Hemorrhage, this subspecialty achieves minimal trauma intervention in functional brain areas, significantly reduces disability and mortality rates, and realizes rapid management within the “golden hour” after admission, providing efficient and high-quality specialized medical services for critically ill patients with hemorrhagic cerebrovascular diseases in the region and surrounding areas. Its diagnosis and treatment level and clinical experience remain at the domestic leading level. The subspecialty actively and diligently studies its business, took the lead domestically in carrying out clinical work related to intracranial hypotension headache, and established a diagnosis and treatment team centered on neurosurgery, neurology, and radiology. Its main clinical research includes imaging diagnosis of intracranial hypotension, treatment and clinical significance of targeted epidural blood patch, and management of subdural hematoma complicated by intracranial hypotension. At present, it has attracted patients with intracranial hypotension from multiple other provinces and cities for diagnosis and treatment, gradually becoming a relatively concentrated treatment center for intracranial hypotension in China. This specialty also carries out treatment of complex hydrocephalus, using neuroendoscopy to manage complex hydrocephalus (endoscopic third ventriculostomy, choroid plexus cauterization), significantly improving treatment effects, shortening patients' hospital stay, and alleviating patients' suffering.
The diagnosis and treatment features of the Hemorrhagic Cerebrovascular Disease Group include: interventional embolization of intracranial aneurysms (simple embolization, single or multiple stent-assisted embolization, balloon-assisted embolization, flow-diverter stent placement, and other procedures), clipping of intracranial aneurysms, interventional embolization and surgical resection of brain arteriovenous malformations (AVM) and dural arteriovenous fistulas (DAVF), interventional embolization of carotid-cavernous fistulas (CCF), interventional embolization and drainage of chronic subdural hematoma, minimally invasive burr-hole drainage for hypertensive intracerebral hemorrhage, intracranial-extracranial bypass or modified intracranial-extracranial vascular revascularization for hemorrhagic moyamoya disease, neuroendoscopic evacuation of intracerebral hematoma, neuroendoscopic third ventriculostomy, Remebot robot-guided burr-hole drainage for brainstem and cerebellar hemorrhage, subtemporal keyhole approach for brainstem hematoma evacuation, epidural blood patch for intracranial hypotension headache, and myelography to locate cerebrospinal fluid leakage points.
V. Craniocerebral Trauma Group
The group is committed to a complete system of work for patients with various types of craniocerebral injury, including acute-phase rescue, intensive care, complication management, rehabilitation and arousal promotion, and clinical research. In the acute phase, relying on the emergency green channel and multidisciplinary team, it rapidly assesses and performs surgery, rapidly removes hematoma, reduces intracranial pressure, and provides the cornerstone of life for critically ill patients. For postoperative patients, it can continuously monitor intracranial pressure, cerebral blood flow, etc., and carry out individualized precise management; at the same time, it carries out chronic-phase rehabilitation and functional reconstruction, cranial bone repair, and management of hydrocephalus.
The diagnosis and treatment features of the Craniocerebral Trauma Group include: intracranial hematoma evacuation, standard large craniectomy decompression/internal and external decompression for intracranial hypertension, complex skull base reconstruction, repair of cerebrospinal fluid otorrhea and rhinorrhea, optic canal decompression, comprehensive treatment of intracranial infection, cranioplasty and burr-hole drainage for chronic subdural hematoma, ventriculoperitoneal shunt for hydrocephalus, and the use of intracranial pressure monitoring and mild hypothermia technology to rescue patients with extremely severe craniocerebral injury.
The Department of Neurosurgery has completed and is conducting more than 20 research projects, including 2 national-level projects and 8 provincial and departmental-level projects. It has obtained more than 50 national patents. It undertakes training and technical guidance for neurosurgery physicians in lower-level hospitals. It has published more than 100 medical papers of various types, including more than 30 SCI papers and more than 10 Chinese Medical Association series papers. It has served as chief editor or co-editor of more than 20 medical monographs.
In clinical work, all medical and nursing staff of the Department of Neurosurgery consistently adhere to the service tenet of “people-oriented, patients supreme,” actively advocate the departmental spirit of “unity, dedication, compliance with regulations, and innovation,” and have formed a professional neurosurgery team with unity and collaboration, excellent service, and superb technology, providing patients with warm, convenient, scientific, and efficient medical services.
Tel: 0538-6237457 (Outpatient), 6237585 (Stroke Clinic); 6237458 (Nurse Station of Ward I of Neurosurgery—Hemorrhagic Cerebrovascular Disease and Craniocerebral Trauma Group), 6230205 (Doctor's Office of Ward I of Neurosurgery—Hemorrhagic Cerebrovascular Disease and Craniocerebral Trauma Group); 6231063 (Nurse Station of Ward II of Neurosurgery—Ischemic Cerebrovascular Disease, Neuromodulation and Restoration, and Brain and Spinal Cord Tumor Group), 6231065 (Doctor's Office of Ward II of Neurosurgery—Ischemic Cerebrovascular Disease, Neuromodulation and Restoration, and Brain and Spinal Cord Tumor Group).